Adrienne S. Brown, EVP and President LLY Imm at Eli Lilly & Co, filed a Form 4 on November 3, 2026, disclosing transactions dated November 1, 2026, involving the conversion of restricted stock units and a related tax-withholding disposition of common stock.

Key Highlights

  • RSU conversion: Brown acquired 2,530 shares of common stock on November 1, 2026, via an M-coded transaction (conversion of restricted stock units) at a price of $0.
  • Shares withheld for taxes: 1,098.656 shares were disposed of on the same date under transaction code F at a price of $1,417.54 per share.
  • Resulting ownership: Following both transactions, Brown directly beneficially owned 9,893.923 shares of common stock.
  • RSU detail: Each restricted stock unit represented a contingent right to receive one share of Eli Lilly and Company common stock, according to the filing.
  • Issuer and exchange: The issuer is Eli Lilly & Co, listed as NYSE:LLY.
  • Signing authority: The form was signed by Jonathan Groff for Adrienne Brown, pursuant to authorization on file.

Adrienne Brown's November 2026 RSU Vesting and Tax Withholding at Eli Lilly

According to the filing, Brown's transactions on November 1, 2026, involved two steps tied to the vesting of restricted stock units. First, 2,530 restricted stock units were converted to 2,530 shares of common stock at a price of $0, reflecting the standard mechanics of RSU settlement as described in the filing's footnote: "Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."

Simultaneously, 1,098.656 shares were disposed of under transaction code F, which the filing records at a per-share price of $1,417.54. This type of F-coded transaction typically represents shares withheld to cover tax obligations at vesting, as reported in the filing. The filing does not characterize this disposal as an open-market sale.

After both transactions, Brown's direct beneficial ownership stood at 9,893.923 shares of common stock, as reported in Table I of the filing. The zero remaining balance in Table II confirms the full settlement of the 2,530 restricted stock units involved. Brown is identified in the filing as an Officer with the title "EVP, President LLY Imm." The filing was submitted on November 3, 2026, covering transactions with an earliest date of November 1, 2026, on NYSE:LLY.

What Was Disclosed

The filing disclosed the vesting of 2,530 restricted stock units into common stock and the concurrent withholding of 1,098.656 shares at $1,417.54 per share for Adrienne S. Brown, leaving her with direct beneficial ownership of 9,893.923 shares of Eli Lilly & Co common stock.